- Prof. Noriyoshi Sawabata
- Nara Medical University, Sch Med, Department Thoracic & Cardiovascular Surgery, 840 Shijo Cho, Kashihara, Nara, Japan.
Special Issue Introduction
According to the change of the population background, the need for less invasive treatment of lung cancer has been increasing. Since the stage I lung cancer is a localized disease without any metastases, mini-invasive local therapies are crucial in high-risk patents with lung cancer due to the low chance of mortality and morbidity. In addition, owing to the development of surgical and diagnostic techniques, bland new clinical, pathological genetic, and epigenetic features have been revealed. As such, the concept of sublober resection for lung cancer has been changing. In the special issue on Mini-Invasive Surgery entitled "New Strategy of Sublober Resection for Lung Cancer" will be enlightened by the authorities of this special issue.
The themes will include:
(1) Physiological risk assessment: up to date and future perspective
(2) Sublober resection of high risk patients for lobectomy: current and future strategy
(3) Sublober resection of normal risk patients for lobectomy: current and future strategy
(4) New surgical technique of sublober resection
(5) Future perspective of sublober resection for lung cancer
Submission Deadline30 Sep 2020